| API Access | |

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Healthcare & Medical Investm: Reports FY26

TOKYO, Mar 17 (Pulse News Wire) – Healthcare & Medical Investment Corporation (3455.T) reported non-consolidated results for fiscal year 2026 ending January. Revenue was ¥2.6 billion (+3.4% YoY). oper

View all Healthcare & Medical Investment Corporation disclosures →

TOKYO, Mar 17 (Pulse News Wire) – Healthcare & Medical Investment Corporation (3455.T) reported non-consolidated results for fiscal year 2026 ending January. 6 billion (+3.4% YoY).

3%). net profit attributable to shareholders was ¥1,057 million (+4.0%).

8 billion with an equity ratio of 43.6%.

Original Disclosure (PDF)

🟢 Confidence: High

Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.

AI-translated content.